Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Niecestro

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drugs|December 8, 2007
The role of sulodexide in the treatment of diabetic nephropathyRam Weiss, Robert Niecestro, Itamar Raz
The American Journal of Cardiology|January 17, 2002
Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemiaJohn R Crouse, Peter Lukacsko, Robert Niecestro, et al.
Expert Review of Endocrinology & Metabolism|February 9, 2019
Ferric citrate: a novel phosphate-binding agentKausik Umanath, Robert Niecestro, Julia B Lewis, et al.
Biopharmaceutics & Drug Disposition|August 31, 2004
Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteersEdward Cullen, James Liao, Peter Lukacsko, et al.
Expert Review of Clinical Pharmacology|September 23, 2014
Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety dataMarvin Sinsakul, Roger Rodby, Kausik Umanath, et al.
Journal of Clinical Pharmacology|February 8, 2002
Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humansJim X Sun, Robert Niecestro, Gale Phillips, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 5, 2026
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy VolunteersRobert Niecestro, Emma C Foster, Lyn Millist, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2014
Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costsRoger Rodby, Kausik Umanath, Robert Niecestro, et al.
Drugs in R&D|August 5, 2015
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial DataRoger A Rodby, Kausik Umanath, Robert Niecestro, et al.
Clinical Therapeutics|February 9, 2002
A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatinMichael H Davidson, Peter Lukacsko, Jim X Sun, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drugs|December 8, 2007
The role of sulodexide in the treatment of diabetic nephropathyRam Weiss, Robert Niecestro, Itamar Raz
The American Journal of Cardiology|January 17, 2002
Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemiaJohn R Crouse, Peter Lukacsko, Robert Niecestro, et al.
Expert Review of Endocrinology & Metabolism|February 9, 2019
Ferric citrate: a novel phosphate-binding agentKausik Umanath, Robert Niecestro, Julia B Lewis, et al.
Biopharmaceutics & Drug Disposition|August 31, 2004
Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteersEdward Cullen, James Liao, Peter Lukacsko, et al.
Expert Review of Clinical Pharmacology|September 23, 2014
Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety dataMarvin Sinsakul, Roger Rodby, Kausik Umanath, et al.
Journal of Clinical Pharmacology|February 8, 2002
Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humansJim X Sun, Robert Niecestro, Gale Phillips, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 5, 2026
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy VolunteersRobert Niecestro, Emma C Foster, Lyn Millist, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2014
Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costsRoger Rodby, Kausik Umanath, Robert Niecestro, et al.
Drugs in R&D|August 5, 2015
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial DataRoger A Rodby, Kausik Umanath, Robert Niecestro, et al.
Clinical Therapeutics|February 9, 2002
A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatinMichael H Davidson, Peter Lukacsko, Jim X Sun, et al.
Pageof 2